Sign In
Buy MRK
$113.87
-1.62 (-1.40%)
At Close: Jun 18, 2026
Is An Earnings Beat In The Cards For Merck Stock?
08:00am, Friday, 26'th Jul 2024
Merck (NYSE: MRK) will report its Q2 2024 results on Tuesday, July 30. We expect the company to post revenue of $15.9 billion and adjusted earnings of $2.20, slightly ahead of the street estimates.
Countdown to Merck (MRK) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS
10:20am, Thursday, 25'th Jul 2024
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Merck (MRK), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quart
Merck Q2 Earnings Preview: We Need To Talk About Keytruda's LOE
01:20pm, Wednesday, 24'th Jul 2024
Merck & Co will announce Q2 2024 earnings on July 30th. Merck's share price has risen 65% in the past 3 years, driven by the success of Keytruda, the world's best-selling drug. Keytruda revenues were
Merck Announces Fourth-Quarter 2024 Dividend
12:52pm, Tuesday, 23'rd Jul 2024
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck Announces Fourth-Quarter 2024 Dividend.
Should You Buy, Sell or Hold Merck (MRK) Ahead of Q2 Earnings?
12:20pm, Tuesday, 23'rd Jul 2024
Investor focus is likely to be on the sales of Merck's (MRK) blockbuster oncology medicine, Keytruda, when the company reports second-quarter 2024 earnings.
Merck (MRK) Earnings Expected to Grow: Should You Buy?
11:07am, Tuesday, 23'rd Jul 2024
Merck (MRK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Billionaires Are Loading Up on This Surging Dow Stock. Should You?
09:30am, Tuesday, 23'rd Jul 2024
Merck's stock has surged 16.8% year-to-date, outpacing the Dow Jones. Keytruda remains a key growth driver, but patent expiration looms in 2028.
Merck's RSV drug meets main goals of mid-to-late stage trial
07:01am, Tuesday, 23'rd Jul 2024
Merck said on Tuesday its respiratory syncytial virus (RSV) drug met the safety and efficacy goals in a mid- to late- stage study testing it in infants.
Merck (MRK) Stock Sinks As Market Gains: Here's Why
06:56pm, Monday, 22'nd Jul 2024
Merck (MRK) closed at $125.69 in the latest trading session, marking a -0.06% move from the prior day.
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names
09:50am, Monday, 22'nd Jul 2024
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Merck & Co., Inc. (MRK) Is a Trending Stock: Facts to Know Before Betting on It
10:01am, Thursday, 18'th Jul 2024
Merck (MRK) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:50am, Thursday, 18'th Jul 2024
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
2 Magnificent Stocks to Buy With $500
04:59am, Thursday, 18'th Jul 2024
Merck's long-term prospects look strong despite a major incoming patent cliff. Novartis' diversified lineup and pipeline, solid results, and dividend record make it an excellent pick.
Zacks Industry Outlook Eli Lilly, Novo Nordisk, Merck and Pfizer
10:41am, Wednesday, 17'th Jul 2024
Eli Lilly, Novo Nordisk, Merck and Pfizer have been highlighted in this Industry Outlook article.
3 Biotech Stocks to Buy in Case of Another Pandemic
01:33pm, Tuesday, 16'th Jul 2024
While the last two major global pandemics were more than 100 years apart, a few international agencies warn of the increased potential for more frequent pandemics. This is admittedly a concerning and
